Hyponatremia and extrapontine myelinolysis in a patient with COVID‐19: A case report

Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis.

Detalles Bibliográficos
Autores principales: Abd Ur Rehman, Muhammad, Abdulrahman, Abdulrahman Fadhl, Zainab, Aariz, Paksoy, Yahya, Kharma, Nadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271216/
https://www.ncbi.nlm.nih.gov/pubmed/34267918
http://dx.doi.org/10.1002/ccr3.4463
Descripción
Sumario:Until we have strong evidence to the contrary, symptomatic hyponatremia should be treated with extra caution in COVID‐19 co‐infection patients as the latter could be another risk factor for the development of extrapontine myelinolysis.

Ejemplares similares